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INTRODUCTION
Laryngoscopy and endotracheal intubation are a 
routine part of general anesthesia.1,2 Laryngoscopy 
and endotracheal intubation are routines performed 
in general anesthesia. Up until now, endotracheal 
intubation is still the best approach in protecting the 
airway from aspiration during general anesthesia. 
The endotracheal tube is also useful in giving posi-
tive pressure ventilation during general anesthe-
sia.1,2 However, from various invasive interventions, 
laryngoscopy and intubation are the strongest pain 
inducer, surpassing the pain caused by rib retrac-
tion, skin incision, and abdominal exploration.3 
Manipulation and instrumentation of airway 
during laryngoscopy and endotracheal intubation 
may cause several complications, such as increased 
heart rate and blood pressure due to sympathetic 
nerve stimulation.2-5 Shribman et  al.6 reported 
that laryngoscopy and intubation have more role 
in hemodynamic changes than laryngoscopy 
only. This cardiovascular response can be malef-
icence for the patients because it can increase the 
need for oxygen in the heart. Activation of the 
 renin-angiotensin-aldosterone system can also 
increase the blood pressure during intubation. 
Increased intracranial pressure can occur due to 
increased cerebral blood flow and can cause harm 
to patients with decreased intracranial compliance. 
In patients with increased airway reactivity, intuba-
tion can trigger bronchospasm, therefore, causing 
a ventilation-perfusion disturbance in the lungs.4,5
Clinicians are struggling in performing an inter-
vention that pharmacologically can suppress the 
cardiovascular response in laryngoscopy and endo-
tracheal intubation.7-10 Clinicians could not find a 
satisfying solution due to inadequate results which 
were not ideal to be performed or administrated 
routinely for their harmful side effects.5,11
The use of lidocaine has been the subject of 
several studies. Lidocaine can be given orally, 
through inhalation, spray, or intravenous admin-
istration.5,12 To facilitate laryngoscopy and intu-
bation, oral or spray administration of lidocaine 
provides an uncomfortable sensation for the 
patient. In addition, the analgesic effect is often 
limited to the oropharynx area, demanding the 
operator to combine it with block techniques or add 
other drugs to make sure the patient feels comfort-
able during the procedure.13,14 
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Introduction: Laryngoscopy and intubation is an invasive procedure 
routinely done during general anesthesia. The cardiovascular response 
to these procedures can be harmful in patients who are vulnerable, 
especially those who have cardiac or cerebrovascular problems. One 
method to attenuates the cardiovascular response was the use of 
anesthetics, including lidocaine. This study aimed to assess the effect 
of inhaled lidocaine on cardiovascular responses after laryngoscopy 
and intubation.
Patients and Methods: This study was a randomized double-
blind clinical trial on 50 subjects who underwent elective surgery, 
24 subjects were given inhaled lidocaine 1.5 mg/kgBW and 25 subjects 
were given 0.9 % NaCl inhalation before laryngoscopy and intubation. 
Cardiovascular parameters being investigated were changes in systolic 
and diastolic blood pressure, mean arterial pressure (MAP) and heart 
rate in a serial manner.
Results: In the first minute after intubation, MAP and heart rate 
were higher in the NaCl group. The difference in MAP was 15.5 mmHg 
(p <0.001) while heart rate was 9.5 beats/min (p <0.001). In the 3rd 
minute after intubation, MAP and heart rate kept different in both 
groups: 16.6 mmHg (p <0.001) and 11.2 beats/minute (p <0.001), 
respectively. In the 5th minute after intubation, MAP and heart rate 
remained different between two groups: 16.7 mmHg (p <0.001) and 
10.0 beats/min (p=0.03), respectively. 
Conclusion: Lidocaine inhalation was able to attenuate cardiovascular 
response due to pain stimuli and sympathetic stimulation after 
laryngoscopy and intubation.
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Intravenous administration of lidocaine will 
increase its plasma levels, which can increase the 
risk of developing side effects, especially in the 
central nervous system due to increased levels of 
toxic lidocaine metabolites. High plasma lidocaine 
levels can also interfere with the cardiovascular 
system. Barriers to sodium ion channels, especially 
in Purkinje fibers and ventricular cells, can cause 
depression of heart muscle contractility.5,11 In a 
study where intravenous lidocaine was adminis-
trated on fibromyalgia patients, 17% of the subjects 
developed hypotension. The major side effects 
reported were lung edema and supraventricular 
tachycardia.15 The Food and Drug Administration 
(FDA) issued a warning stating that even an infil-
tration or nerve block using lidocaine must be 
performed very carefully and administration of 
lidocaine into the blood vessels should be avoided.16
To suppress the cardiovascular response towards 
laryngoscopy, one of the alternatives is to admin-
ister lidocaine via inhalation. The administration 
of inhaled lidocaine will produce a topical, rather 
than systemic, effect on the respiratory tract. A 
lidocaine inhalation at a dose of 4 mg/kgBW will 
produce the same serum level as a 2 mg/kgBW dose 
of intravenous lidocaine.5 Also, out of 25 people 
who received lidocaine inhalation with an aver-
age dose of 8.7  mg/kgBW, plasma levels <5 mg/L 
were obtained, demonstrating that lidocaine can 
be safely administered through inhalation without 
producing toxic plasma levels.5
The respiratory tract has a wide drug absor-
bance area with high permeability supported by 
good vascularization in airway epithelium. Drug’s 
effectivity will be accomplished when the inhaled 
medication enters the systemic flow. Air-to-blood 
transfer starts when the drug interacts with 
tracheobronchial mucosa and surfactant in alve-
olus and can be absorbed quickly so the drug is 
not eliminated by the mucociliary response and 
macrophage in the airway. The drug absorption 
can occur because of the active and passive trans-
port through the paracellular and transcellular 
transport pores.17 Local anesthesia, such as lido-
caine, in the airway mucosa, is effective if admin-
istrated topically and can decrease the reactivity 
of airway. Lidocaine is the most common airway 
topical anesthesia used.18
Aboumadi15 and Sklar11 reported that lidocaine 
inhalation can suppress the increased pulse rate and 
blood pressure due to laryngoscopy and intubation. 
With slightly deeper respiration for 15-30 minutes, 
lidocaine can give an anesthetic effect in orophar-
ynx and trachea.16 Administration of lidocaine by 
inhalation is relatively safer, more comfortable, 
easier and cheaper for the patients. This study 
aimed to assess the effect of inhaled lidocaine on 
cardiovascular responses after laryngoscopy and 
intubation.
PATIENTS AND METHODS
This study is a double-blind, randomized clinical trial 
to assess the effect of lidocaine inhalation 1.5  mg/
kgBW compared to NaCl 0.9% inhalation on the 
changes of pulse rate and blood pressure during laryn-
goscopy and intubation intervention. The study was 
conducted in Cipto Mangunkusumo Hospital. The 
study protocol was approved by the local Committee 
of Ethical Clearance. All subjects involved provided 
written informed consent to be included in this study.
Inclusion criteria include patients underwent 
general anesthesia with laryngoscopy and endotra-
cheal intubation, aged 18-55 years old, having a body 
weight of 40-65 kg, ASA I-II, with Mallampati I-II 
upon pre-anesthesia examination. The exclusion 
criteria include patients with cardiovascular diseases, 
pregnancy, airway difficulty, and airway reactivity. 
The drop-out criteria were intubations performed 
more than once, the time needed for laryngoscopy 
and intubation was more than 45 seconds, and signs 
of hypoxia during laryngoscopy intervention. 
The subjects were assigned randomly to one 
of these two groups: Group L (Lidocaine) and 
Group P (placebo, NaCl 0.9%). Randomization 
was performed using a random table which was 
downloaded from www.randomizer.org. The choice 
of intervention was put in an envelope as conceal-
ment. The intervention towards subjects of both 
groups was prepared by the third party who was not 
involved in this study. The researcher, anesthetists, 
and the patients involved did not know the medi-
cations given. The inhalation of either lidocaine or 
placebo was given 15-30 minutes prior to the anes-
thesia by Omron nebulizer Ne-C28.
Cardiovascular variables such as systolic and 
diastolic blood pressure, mean arterial pressure 
(MAP), and pulse rate, was measured in series. 
Data T0 was the measurement of pulse rate and 
blood pressure right before inhalation was given. 
Data T1 was the measurement after the inhala-
tion was given. Premedication used was 0.05  mg/
kgBW midazolam and 2 µg/kgBW fentanyl. 
Two  minutes after the premedication, T2 was 
recorded. Induction was performed using propofol 
2 mg/kgBW followed by muscle relaxant of 0.5 mg/
kgBW atracurium and manual ventilation support. 
Just before the laryngoscopy and intubation proce-
dure, T3 was recorded. Endotracheal intubation 
was performed by an advanced anesthesiology 
resident. This procedure must be done in less than 
45 seconds and in one attempt. One minute after 
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intubation, T4a was measured, followed by T4b and 
T4c on minute-3 and minute-5, respectively. 
The data were processed using the SPSS 16.0 soft-
ware. The result was described in mean and standard 
deviation. The difference test of both numeric variables 
was the comparison of the mean of both groups using 
unpaired t-test if the data distribution was normal and 
the data variance was indifferent. If the data distribu-
tion was not normal or the data variance was different, 
Mann-Whitney test would be performed. A p-value of 
<0.05 was considered significant.
RESULTS
This study was conducted in 50 subjects. One 
subject dropped out due to the time duration 
needed to perform laryngoscopy and intubation 
was more than 45 seconds. Therefore, the total 
number of patients analyzed was 49. The majority 
of the subjects (63.3%) was female with a median 
age of 33 (18-55) years old. Description of subjects’ 
characteristics is shown in Table 1.
In both groups, the baseline value (T0) does 
not have any significant difference in the mean of 
the four cardiovascular variables (systolic blood 
pressure, diastolic blood pressure, MAP, and pulse 
rate) as shown in Table 2. The mean of post-inha-
lation cardiovascular response until 5 minutes after 
intubation (T1-T4C) can be seen in Table 3. From 
T1-T3 data, we found that both groups did not have 
any significant differences.
T2 and T3 values showed no significant differ-
ence in the tendency of cardiovascular responses to 
decrease. Measurements of T3-T4C in both groups 
showed more pronounced changes, with the lido-
caine group showing smaller values than the NaCl 
group.
The researchers then compared the differences 
in cardiovascular variables between the two groups 
after laryngoscopy and intubation to determine the 
significance level of these differences with unpaired 
t-test or Mann-Whitney test (Table 4). There were 
significant differences in all cardiovascular parame-
ters in the 1st, 3rd and 5th-minute post-intubation 
(p <0.05).
Mean difference of changes in the cardiovascular 
responses are schematically presented in figure 1, 
2, 3 and 4. It appears that in all four cardiovascular 
variables, the group with lidocaine inhalation was 
more stable post-intubation. The unpaired t-test or 
Mann-Whitney between the two groups showed 
a significant difference in the four cardiovascular 
variables in T4A to T4C (p <0.05). 
Three minutes after intubation (T4B), the 
difference in systolic blood pressure between the 
two groups became 13.8 (95% CI 5.4-22.2) mmHg 
(p <0.001), diastolic blood pressure 11.8 (95% CI 6, 
5-17.2) mmHg (p <0.001), difference in MAP 12.9 
(95% CI 6.4-19.3) mmHg (p <0.001) and difference 
in heart rate 12.0 (95% IK 6, 3-17.8) beats/minute 
(p <0.001). 
This difference continued up to five minutes 
post-intubation (T4C). The difference in systolic 
blood pressure became 15.2 (95% CI 10.4-20.1) 
mmHg (p <0.001), diastolic blood pressure 11.7 
(95% CI 7.0-16.3) mmHg (p < 0.001), MAP 
Table 1  Characteristics of Subjects
Characteristic
Lidocaine (L) group
N = 24
NaCl 0.9% (P) group
N = 25
Sex, n(%) 
Male 10 (41.7) 8 (32.0)
Female 14 (58.3) 17 (68.0)
Age (years), median(min-max) 30 (18-55) 42 (19-55)
ASA physical status, n(%)
1 7 (29.2) 8 (32.0)
2 17 (70.8) 17 (68.0)
ASA: American Society of Anesthesiologists
Table 2  Characteristics of cardiovascular response in both group in T0 (mean±SD)
Cardiovascular variables
Lidocaine
N= 24
NaCl
N=25
Systolic blood pressure (mmHg) 125,6 ± 9,7 125,6 ± 13,9
Diastolic blood pressure (mmHg) 80 (64-90) 77,0 ± 7,0
MAP (mmHg) 92,3 ± 6,3 93,3 ± 10,8
Pulse rate (x/minute) 80 (65-116) 84,2 ± 13,4
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113.0  (95% CI 8.4-17.5) 2.9 (95% CI 6.4-19.3) 
mmHg (p <0.001) and heart rate 10.8 (95 % CI 
4.4-17.2) beats/minute (p <0.001).
In the first minute after intubation (T4A), the 
comparison of cardiovascular variables between 
the NaCl and lidocaine groups was as follows. 
The difference in systolic blood pressure between 
the NaCl and lidocaine groups was 14.5 (95% CI 
8.3-20.7) mmHg (p <0.001). The diastolic blood 
pressure of the NaCl group was 8.8 (95% CI 
3.0-14.7) mmHg (p = 0.001). MAP difference was 
11.7 (95% CI 6.4-17.0) mmHg (p <0.001) while the 
difference in pulse rate was 10.3 (95% CI 4.0-16.5) 
beats/minute (p <0.001).
In this study, researchers also collected data on 
the subjects’ convenience when given lidocaine 
inhalation. As many as 17 of the 24 subjects with 
lidocaine inhalation (70.8%) reported a bitter 
sensation in the mouth during inhalation. No other 
complaints were found during monitoring.
Table 3  Post-inhalation cardiovascular responses in the two groups during intervention
Hemodynamic variable T1 T2 T3 T4A T4B T4C
NaCl 0.9%
Systolic (mmHg) 126.0 ± 12.0 113.5± 11.4 96.3 ± 14.6 127 (80-135) 123.2 ± 18.5 119.9 ± 9.2
Diastolic (mmHg) 78.5 ± 8.4 71.0 ± 8.2 61.4 ± 10.8 79 (50-91) 77.8 ± 9.3 75.0 ± 8.2
MAP (mmHg) 93.9 ± 9.8 85.0 ± 8.6 72.9 ± 11.1 96 (60-101) 92.4 ± 13.3 90.0 ± 7.9
Heart rate (beats/minute) 88 (53-105) 76.0 ± 9.6 72.2 ± 9.8 82.2 ± 13.2 82.6 ± 12.0 80.7 ± 13.6
Lidocaine
Systolic (mmHg) 125.0 ± 10.3 111.6 ± 10.5 104.2 ± 7.2 109.6 ± 9.3 112 (90-120) 104.6 ± 7.7
Diastolic (mmHg) 77.9 ± 8.1 69.3 ± 7.2 63.3 ± 8.1 66.4 ± 10.1 66.0 ± 9.3 65 (40-83)
MAP (mmHg) 92.2 ± 8.1 82.3 ± 6.7 76.7 ± 6.7 80.2 ± 9.4 81 (55-91) 76 (55-96)
Heart rate (beats/minute) 80 (64-106) 75(60-106) 69 (58-100) 71.9 ± 7.6 71 (54-80) 72 (51-81)
Numerical data with normal distribution are shown in mean ± SD. 
Numerical data with abnormal distribution are displayed in the median with minimum and maximum values. 
T1: post-inhalation; T2: post-coinduction; T3: post-induction; T4 A-C: 1, 3, and 5 minutes after laryngoscopy and intubation; MAP: mean arterial pressure
Table 4  Comparison of the cardiovascular response changes after laryngoscopy and intubation between the two 
groups
Cardiovascular variable
Lidocaine
N= 24
NaCl
N=25 p 95% CI
Systolic blood pressure
1 minute post-intubation 5.4 ± 8.4 27.8 ± 14.9 <0.001a 22.5 (15.5-29.4)
3 minutes post-intubation 5.3 ± 11.1 32.0 (-22.0-51.0) <0.001b 21.7 (12.8-30.6)
5 minutes post-intubation 0.4 ± 9.7 23.6 ± 12.8 <0.001a 23.2 (16.6-29.7)
Diastolic blood pressure
1 minute post-intubation 3.1 ± 10.4 13.8 ± 14.1 0.004 a 10.7 (3.6-17.8)
3 minutes post-intubation 2.7 ± 10.1 16.4 ± 12.8 <0.001a 13.7 (7.1-20.4)
5 minutes post-intubation 0.1 ± 9.9 13.6 ± 10.7 <0.001a 13.6 (7.6-19.5)
MAP
1 minute post-intubation 3.5 ± 9.2 19.0 ± 12.2 <0.001a 15.5 (9.2-21.7)
3 minutes post-intubation 2.9 ± 9.7 19.5 ± 14.1 <0.001a 16.6 (9.6-23.6)
5 minutes post-intubation 0.4 ± 8.9 17.1 ± 9.9 <0.001a 16.7 (11.3-22.2)
Heart rate
1 minute post-intubation 1.5 (-27.0-10.0) 10.0 ± 8.6 <0.001b 9.5 (4.8-14.2)
3 minutes post-intubation 1.0 (-34.0-14.0) 10.4 ± 10.7 <0.001b 11.2 (5.2-17.2)
5 minutes post-intubation 0.0 (-42.0-10.0) 8.5 ± 11.6 0.003 b 10.0 (3.5-16.5)
Note: Numerical data with normal distribution are shown in mean ± SD. Numerical data with abnormal distribution are displayed in the median with minimum 
and maximum values. The data shows differences in cardiovascular variables between post=intubation (T4A-C) and post-induction (T3). aUnpaired t-test; bMann-
Whitney test
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DISCUSSION
In this study, we found that lidocaine inhalation 
before laryngoscopy and intubation provided bene-
fits in maintaining the cardiovascular conditions of 
post-intubation patients. The study by Shribman 
et al.19 demonstrated that laryngoscopy stimulates 
pain, observed from the surge of sympathoadrenal 
response, which then increases both the patient’s 
blood pressure and heart rate. This response comes 
from the stimulation of the supraglottic region. In 
addition, intubation further increases this response 
due to tube placement through the vocal cords and 
the presence of expanding cuffs in the infraglottic 
region.
Laryngoscopy only provides a moderate stimulus 
while intubation increases the degree of the stim-
ulus. Changes in cardiovascular responses occur 
due to these stimulations and can be objectively 
measured by an increase in the patient’s catechol-
amine levels. Efferent sympathetic stimuli toward 
the heart originate from the T1-T4 spinal cord, and 
those toward the adrenal medulla originate from 
T3-L3. Supraspinal modulation also plays a role in 
this arrangement.17 The sympathoadrenal response 
can cause a surge in blood pressure up to 40-50% in 
the first to fifth minutes post-intubation.18 
A similar phenomenon is observed from changes 
in cardiovascular variables in the control group 
of this study. A surge of cardiovascular response 
changes occur from the first minute after intubation 
with an increase in blood pressure and MAP up to 
around 20-30% (table 3). Such responses remained 
pronounced even when the patient was under 
general anesthesia. Therefore, efforts to reduce 
these responses are needed to improve patient 
safety and comfort.
Kovac5 stated that efforts to minimize cardio-
vascular responses are important especially if 
the patient has cerebrovascular or cardiovascular 
abnormalities because intubation can increase 
intracranial and intraocular pressure. Nearly half 
of patients with coronary heart disease experience 
episodes of post-intubation ischemia.20-22 
The findings of this study are in line with find-
ings by Venus et al.23 and Sklar et al.,11 who found 
that lidocaine inhalation was able to suppress heart 
rate changes in post-intubation subjects. Compared 
to changes in cardiovascular variables at the time 
after induction, systolic and diastolic blood pres-
sure, MAP, and heart rate at 1 minute, 3 minutes, 
and 5 minutes after intubation in both groups had 
significant mean differences. After induction of 
anesthesia, the lidocaine group had more stable 
cardiovascular variables and the smaller changes 
compared to the control group.
Both the lidocaine and NaCl 0.9% in this study 
were given through inhalation. The types of drugs 
given to the subjects also do not affect blood pres-
sure and heart rate, so from the beginning, the two 
groups were in a balanced hemodynamic condi-
tion. A clinical trial that specifically compared 
Figure 1  Mean difference of changes in systolic blood pressure between sub-
jects with NaCl and lidocaine inhalation
Figure 2  Mean difference of changes in diastolic blood pressure between 
subjects with NaCl and lidocaine inhalation
Figure 3  Mean difference of changes in MAP between subjects with NaCl 
and lidocaine inhalation
Figure 4  Mean difference of changes in heart rate between subjects with 
NaCl and lidocaine inhalation
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lidocaine inhalation and control (NaCl) came from 
the study by Venus et al.23 who found that inhaled 
(aerosolized) lidocaine did not cause changes in 
cardiovascular responses, compared to the signifi-
cant increase in cardiovascular responses that the 
control group experienced.
At toxic doses or at plasma levels that are high 
enough, a level of lidocaine exceeding 5 mg/L 
can induce several adverse effects, one of which is 
cardiovascular impairment, which can cause hemo-
dynamic disorders. At the usual dosage of lidocaine, 
these adverse effects can be avoided and impose no 
effects on hemodynamics.22 This is in line with our 
current study, which compared the effect of lido-
caine inhalation with a control group. Statistically 
and clinically, there were no significant differences 
in post-inhalation cardiovascular responses in the 
two treatment groups.
The right dose of lidocaine to suppress cardio-
vascular responses during laryngoscopy and intu-
bation cannot yet be determined. This is because 
subjects also received fentanyl at 2 µg/kgBW, 
deeming it possible for the drugs to create a syner-
gistic effect in suppressing cardiovascular responses 
during laryngoscopy and intubation.
This study also found that patients given lido-
caine inhalation felt quite comfortable. General 
complaints such as a bitter taste in the mouth do not 
have a significant impact on patients, therefore still 
acceptable for routine use. This study did not find 
any significant adverse effects of lidocaine inhala-
tion. Available evidence reveals the safe dosage of 
lidocaine inhalation to be 100-200 mg with a maxi-
mum tolerable dose of 600 mg. Inhaled lidocaine 
can prevent bronchial hyperreactivity, making it 
possible for off-label use in asthmatic patients. 
Inhaled lidocaine provides local and spasmolytic 
anti-inflammatory effects.23 Regarding the safety of 
lidocaine inhalation, Lim et al. conducted a long-
term study in patients using lidocaine inhalation 
for symptoms of chronic cough and discovered no 
significant adverse effects.24
LIMITATIONS OF THE STUDY
This study has several limitations. First, the equip-
ment used for inhalation was an inhalation mask. 
This mask has a maximum limit for accommodat-
ing the fluid that will eventually evaporate from 
the administration of oxygen at 8-10 L/minute, 
demanding the researchers to limit the weight of 
patients who could participate in this study.
Another limitation was that the researchers did 
not monitor swallowing difficulties and hemo-
dynamic changes after anesthesia, because the 
incidence of complications and adverse effects 
due to lidocaine inhalation still has the potential 
to occur at more than 5 minutes after the induc-
tion of anesthesia. Undetected problems related 
to side effects and complications from lidocaine 
inhalation may exist beyond the time of post-in-
duction observation. The occurrence of sore throat 
related to post-intubation complications was also 
not assessed, considering its frequent occurrence 
after intubation. The same applies for swallowing 
difficulties during inhalation. The administration 
of lidocaine through inhalation can cause difficulty 
in swallowing, which may be dangerous for the 
patient or significantly reduce comfort. In the treat-
ment group, the majority of patients only reported 
a bitter taste in the mouth, so it can be assumed that 
the dose of 1.5 mg/kgBW of lidocaine did not cause 
difficulty in swallowing.
This study did not measure systemic levels of 
catecholamine and lidocaine. Blood catecholamine 
level is a systemic marker of increased sympathetic 
tone associated with cardiovascular responses. 
Measurement of the plasma level of lidocaine in 
this study can help inform the safety and tolerance 
of lidocaine inhalation.
The disadvantage of the inhalation technique in 
this study is a prolonged time for anesthesia prepa-
ration. The inhalation procedure needs 30 minutes 
to perform before anesthesia. 
CONCLUSION
Lidocaine inhalation was able to attenuate cardio-
vascular response due to pain stimuli and sympa-
thetic stimulation after laryngoscopy and intubation 
better compared to NaCl 0.9% inhalation.
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